Magnetar Financial’s Quest Diagnostics DGX Stock Holding History

Magnetar Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,632	Closed	-$1.39M	–	1077
2020 Q4	$1.39M	Buy	11,632 +2,390	+26%	+$291K	0.02%	415
2020 Q3	$1.06M	Sell	9,242 -16,758	-64%	-$1.98M	0.02%	335
2020 Q2	$2.96M	Buy	26,000 +19,373	+292%	+$2.05M	0.09%	142
2020 Q1	$532K	Buy	+6,627	New	+$686K	0.01%	270
2018 Q4	–	Sell	-13,470	Closed	-$1.45M	–	344
2018 Q3	$1.45M	Buy	+13,470	New	+$1.48M	0.03%	108
2017 Q2	–	Sell	-24,278	Closed	-$2.38M	–	835
2017 Q1	$2.38M	Buy	+24,278	New	+$2.31M	0.03%	168
2015 Q3	–	Sell	-4,108	Closed	-$298K	–	432
2015 Q2	$298K	Buy	+4,108	New	+$303K	﹤0.01%	369

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Magnetar Financial's DGX Position: Q1 2021 in Review

Magnetar Financial sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 11,632 shares — an estimated $1.39M sold.

Magnetar Financial first reported a position in DGX in Q2 2015 and held it in 7 quarters. The position peaked at $2.96M in Q2 2020. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

Magnetar Financial reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
Magnetar Financial sold 11,632 Quest Diagnostics shares in Q1 2021, an estimated $1.39M.
Magnetar Financial first reported a position in Quest Diagnostics in Q2 2015 and held it in 7 quarters.
Magnetar Financial's Quest Diagnostics position peaked at $2.96M in Q2 2020.
817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Magnetar Financial's 13F filing for Q1 2021, filed 14 May 2021.